Literature DB >> 18972274

Poor sensitivity of symptoms in early detection of COPD.

Keiichiro Akamatsu1, Toshiyuki Yamagata, Yohei Kida, Hiroto Tanaka, Hiroki Ueda, Masakazu Ichinose.   

Abstract

The prevalence of chronic obstructive pulmonary disease (COPD) has been increasing. However, COPD is often underdiagnosed. The objective of this study was to determine how many outpatients had persistent airflow limitation and could be diagnosed as COPD by post-bronchodilator spirometry. We also evaluated whether the newly diagnosed patients had any symptoms. All outpatients with liver or general diseases over 40 years old who regularly visited to our hospital were tested for pulmonary function by spirometry. Patients with airflow limitation by the first screening spirometry had further examinations including post-bronchodilator spirometry and chest radiograph by pulmonary specialists. A total of 288 patients accepted a first spirometry. The most common chronic diseases of these patients were chronic hepatitis (33.7%), fatty liver (26.4%), liver cirrhosis (8.3%), diabetes (3.5%) and hypertension (3.1%). Approximately half of the patients had a smoking history. 44 of 288 patients (15.3%) showed airflow limitation by pre-bronchodilator spirometry. Of these, 8 patients did not show airflow limitation by a repeat pre-bronchodilator spirometry nor did 5 patients by post-bronchodilator spirometry. The rest were diagnosed as COPD (80.6%), asthma (16.1%) and bronchiectasis (3.2%). The prevalence of COPD was 8.7%. Approximately half of the patients (13/25, 52.0%) diagnosed as COPD had never complained of any respiratory symptoms. Because symptoms such as dyspnea on exertion, cough and sputum are less sensitive for the diagnosis of COPD, the propagation of spirometry in a general practice/setting should be recommended for establishing the diagnosis rate of COPD rather than relying on the presence of respiratory symptoms.

Entities:  

Mesh:

Year:  2008        PMID: 18972274     DOI: 10.1080/15412550802363303

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  7 in total

1.  Misdiagnosis Among Frequent Exacerbators of Clinically Diagnosed Asthma and COPD in Absence of Confirmation of Airflow Obstruction.

Authors:  Vipul V Jain; D Richard Allison; Sherry Andrews; Janil Mejia; Paul K Mills; Michael W Peterson
Journal:  Lung       Date:  2015-04-29       Impact factor: 2.584

Review 2.  Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Authors:  Thomas Glaab; Claus Vogelmeier; Roland Buhl
Journal:  Respir Res       Date:  2010-06-17

3.  COPD is frequent in conditions of comorbidity in patients treated with various diseases in a university hospital.

Authors:  Akira Yamasaki; Kiyoshi Hashimoto; Yasuyuki Hasegawa; Ryota Okazaki; Miki Yamamura; Tomoya Harada; Shizuka Ito; Soichiro Ishikawa; Hiroki Takami; Masanari Watanabe; Tadashi Igishi; Yuji Kawasaki; Eiji Shimizu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-10-05

4.  Missed diagnosis and overtreatment of COPD among smoking primary care population in Central Greece: old problems persist.

Authors:  Eirini Stafyla; Ourania S Kotsiou; Konstantina Deskata; Konstantinos I Gourgoulianis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-02-05

5.  Flow-Volume Parameters in COPD Related to Extended Measurements of Lung Volume, Diffusion, and Resistance.

Authors:  Linnea Jarenbäck; Jaro Ankerst; Leif Bjermer; Ellen Tufvesson
Journal:  Pulm Med       Date:  2013-06-13

6.  Body plethysmography in chronic obstructive pulmonary disease patients: A cross-sectional study.

Authors:  Yogesh Satyendra Gupta; Swati S Shah; Chaya K Ahire; Prathamesh Kamble; Anupam S Khare; S S More
Journal:  Lung India       Date:  2018 Mar-Apr

7.  Predictors of COPD in symptomatic smokers and ex-smokers seen in primary care.

Authors:  Oliver Djurhuus Tupper; Peter Kjeldgaard; Anders Løkke; Charlotte Suppli Ulrik
Journal:  Chron Respir Dis       Date:  2018-02-27       Impact factor: 2.444

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.